Maia Szalavitz is the author, most recently, of Unbroken Brain: A Revolutionary New Way of Understanding Addiction, which will be released in paperback in May. She has written about neuroscience and addiction for nearly 30 years for publications ranging from the New York Times and Washington Post to TIME and Scientific American.
Maia Szalavitz
Neuroscience Journalist
Freelance
From this contributor
Autism’s hidden habit
Conventional wisdom holds that people with autism don't get hooked on alcohol or other drugs, but new evidence suggests otherwise.
New tests extend prospects for ‘reading the mind in the eyes’
Researchers have revamped a screen for ‘mind blindness’ — an impaired understanding of others’ intentions and perspectives — which is a key deficit in autism. The revised test may shed light on how autism develops.
New tests extend prospects for ‘reading the mind in the eyes’
By
Maia Szalavitz
8 April 2014 | 3 min read
‘Resting’ autism brains still hum with activity
Even at rest, the brains of people with autism manage more information than those of their peers, according to a new study that may provide support for the so-called ‘intense world’ theory of autism.
‘Resting’ autism brains still hum with activity
By
Maia Szalavitz
21 February 2014 | 3 min read
First 1,000 days of life could hold keys to autism
Autism researchers have high hopes for a new project called the First 1,000 Days of Life, which aims to follow 5,000 women and their babies from pregnancy through two years after birth.
First 1,000 days of life could hold keys to autism
By
Maia Szalavitz
17 February 2014 | 4 min read
Long neglected, severe cases of autism get some attention
A large new project aims to link specialized psychiatric units across the U.S. to investigate the causes and best treatment for autism’s most severe and challenging cases.
Long neglected, severe cases of autism get some attention
By
Maia Szalavitz
19 December 2013 | 5 min read
Explore more from The Transmitter
Personalized medicine; astroglia organoids; fast track for fragile X drug
Here is a roundup of autism-related news and research spotted around the web for the week of 20 January.
Personalized medicine; astroglia organoids; fast track for fragile X drug
Here is a roundup of autism-related news and research spotted around the web for the week of 20 January.
By
Jill Adams
21 January 2025 | 2 min read
Neuroscientists need to do better at explaining basic mental health research
The knowledge gap between scientists, health-care professionals, policymakers and people with mental health conditions is growing, slowing the translation of basic science to new treatments. Like lawyers learning to present a case to the court, scientists should learn to educate nonscientists about their findings.
Neuroscientists need to do better at explaining basic mental health research
The knowledge gap between scientists, health-care professionals, policymakers and people with mental health conditions is growing, slowing the translation of basic science to new treatments. Like lawyers learning to present a case to the court, scientists should learn to educate nonscientists about their findings.
By
Omar Abubaker, Karla Kaun, Eric J. Nestler
21 January 2025 | 7 min read
Dose, scan, repeat: Tracking the neurological effects of oral contraceptives
We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.
Dose, scan, repeat: Tracking the neurological effects of oral contraceptives
We know little about how the brain responds to oral contraceptives, despite their widespread use. I am committed to changing that: I scanned my brain 75 times over the course of a year and plan to make my data openly available.
By
Carina Heller
20 January 2025 | 7 min read